Methenamine Hippurate 1000 MG

DRUG2 trials

Sponsors

Washington University School of Medicine, University of Oslo

Conditions

Female Urogenital DiseasesRecurrent Urinary Tract InfectionUTIUTI - Lower Urinary Tract Infection

Phase 4

Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention

WithdrawnNCT03996057

Washington University School of MedicineFemale Urogenital Diseases, UTI, UTI - Lower Urinary Tract Infection

Start: 2018-06-20End: 2022-02-11Updated: 2022-07-08

The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI

CompletedNCT04077580

University of OsloRecurrent Urinary Tract Infection

Start: 2019-11-01End: 2023-06-30Updated: 2024-09-03

Related Papers

Methenamine hippurate as prophylaxis for recurrent urinary tract infections in older women—a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU)

Clinical Microbiology and Infection2025-07-153 citations

Methenamine hippurate to prevent recurrent urinary tract infections in older women: protocol for a randomised, placebo-controlled trial (ImpresU)

BMJ Open2022-11-0114 citations